Literature DB >> 30561055

Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome.

Susan Darroudi1, Narges Fereydouni1, Maryam Tayefi2,3, Mahsa Ahmadnezhad4, Parvin Zamani5, Batool Tayefi6, Jasmin Kharazmi7, Shima Tavalaie8, Alireza Heidari-Bakavoli9, Mahmoud R Azarpajouh10, Gordon A Ferns11, Amir H Mohammadpour11,12, Habibollah Esmaily13, Majid Ghayour-Mobarhan8.   

Abstract

Obesity is an important feature of the metabolic syndrome and is associated with an increased risk of type 2 diabetes mellitus, cardiovascular disease, and some cancers. The aim of this study was to determine the relationship between body fat percentage and an imbalance of the prooxidant/antioxidant balance (PAB), serum superoxide dismutase (SOD1) and inflammation (serum hs-CRP) and increase risk of metabolic syndrome and diabetes mellitus. In this study, 9154 individuals were recruited as part of the Mashhad Stroke and Heart Association Disorder (MASHAD) study. Subjects were categorized into two groups according to body fat percentage as defined >25% in male and > 30% in female, according to gender. Biochemical factors, including serum PAB, SOD1, and hs-CRP were measured in all subjects. SPSS version 18 was used for statistical analyses for all. GraphPad Prism 6 for figures was used. Of total number of subjects (9154), 6748 (73.7%) were found to have a high body fat (BF) percentage. Serum hs-CRP and PAB were significantly higher in individuals with a high BF percentage (P < 0.05) but SOD1 was not significantly different between the two groups (P > 0.05). BF percentage, serum PAB and serum hs-CRP were significantly higher in individuals with metabolic syndrome and diabetes versus those without metabolic syndrome and diabetes mellitus (P < 0.05), however serum SOD1 was significantly lower in individuals with metabolic syndrome (P < 0.005). Oxidative stress and inflammation are two factors that may link the presence of high BF percentage with the development of metabolic syndrome, diabetes, and cardiovascular disease.
© 2018 BioFactors, 45(1):35-42, 2019. © 2018 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  SOD1; metabolic syndrome; oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 30561055     DOI: 10.1002/biof.1459

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  12 in total

1.  Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome.

Authors:  Ali Najafi; Morteza Pourfarzam; Fouzieh Zadhoush
Journal:  J Res Med Sci       Date:  2021-01-28       Impact factor: 1.852

2.  Relationship between Decreased Serum Superoxide Dismutase Activity and Metabolic Syndrome: Synergistic Mediating Role of Insulin Resistance and β-Cell Dysfunction.

Authors:  Yiwen Liu; Chifa Ma; Lu Lv; Pingping Li; Chunxiao Ma; Shuli He; Jingbo Zeng; Fan Ping; Huabing Zhang; Wei Li; Lingling Xu; Yuxiu Li
Journal:  Oxid Med Cell Longev       Date:  2020-06-12       Impact factor: 6.543

3.  Calcium-Sensing Receptor in Adipose Tissue: Possible Association with Obesity-Related Elevated Autophagy.

Authors:  Pamela Mattar; Sofía Sanhueza; Gabriela Yuri; Lautaro Briones; Claudio Perez-Leighton; Assaf Rudich; Sergio Lavandero; Mariana Cifuentes
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

4.  Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.

Authors:  Tomonori Sugiura; Yasuaki Dohi; Hiroyuki Takase; Satoshi Fujii; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

5.  Shared genetic etiology and causality between body fat percentage and cardiovascular diseases: a large-scale genome-wide cross-trait analysis.

Authors:  Zhenhuang Zhuang; Minhao Yao; Jason Y Y Wong; Zhonghua Liu; Tao Huang
Journal:  BMC Med       Date:  2021-04-29       Impact factor: 8.775

6.  Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.

Authors:  Yuanting Ding; Heng Liu; Mofei Cen; Yuxiang Tao; Chencen Lai; Zhi Tang
Journal:  Neurochem Res       Date:  2020-11-02       Impact factor: 3.996

Review 7.  Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial Dysfunction.

Authors:  Giovanni Pagano; Federico V Pallardó; Beatriz Porto; Maria Rosa Fittipaldi; Alex Lyakhovich; Marco Trifuoggi
Journal:  Antioxidants (Basel)       Date:  2020-01-18

8.  Development of Metabolic Syndrome Decreases Bone Mineral Density T-Score of Calcaneus in Foot in a Large Taiwanese Population Follow-Up Study.

Authors:  Hsuan Chiu; Mei-Yueh Lee; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen
Journal:  J Pers Med       Date:  2021-05-20

9.  "Obesity and Insulin Resistance" Is the Component of the Metabolic Syndrome Most Strongly Associated with Oxidative Stress.

Authors:  Grzegorz K Jakubiak; Kamila Osadnik; Mateusz Lejawa; Tadeusz Osadnik; Marcin Goławski; Piotr Lewandowski; Natalia Pawlas
Journal:  Antioxidants (Basel)       Date:  2021-12-29

Review 10.  Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions.

Authors:  Yan Hao; Ya-Juan Zhu; Song Zou; Pei Zhou; Ya-Wen Hu; Qi-Xiang Zhao; Lin-Na Gu; Hao-Zhou Zhang; Zhen Wang; Jiong Li
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.